The Oral Health Status of Patients with Peripheral Vascular Disorders : A Systematic Review by Almoosawy, Sayed Abdulmotaleb et al.
Review Copy
The Oral Health Status of Patients with Peripheral Vascular 
Disorders: A Systematic Review
Journal: Vascular
Manuscript ID VASCULAR-07-20-OA-1871.R1
Manuscript Type: Original Article
Date Submitted by the 
Author: 14-Aug-2020
Complete List of Authors: Almoosawy, Sayed Abdulmotaleb; University of Aberdeen, School of 
Medicine, Medical Sciences and Nutrition
McGowan, Mhairi; University of Aberdeen, Institute of Dentistry
Hijazi, Karolin; University of Aberdeen, Institute of Dentistry
Patey, Rona; University of Aberdeen, School of Medicine, Medical 
Sciences and Nutrition
Bachoo, Paul; Aberdeen Royal Infirmary, Department of Vascular 
Surgery
Cherukara, George; University of Aberdeen, Institute of Dentistry
Keywords: Vascular medicine, Peripheral vascular disease, Oral health
 
Confidential Material
VASCULAR
Review Copy
1
Title: The Oral Health Status of Patients with Peripheral Vascular Disorders: A Systematic 
Review
Running head: Oral health and peripheral vascular disorders
Type of manuscript: Original research article
Sayed Abdulmotaleb Almoosawy1
Mhairi McGowan2
Karolin Hijazi2
Rona Patey1
Paul Bachoo3
George Cherukara2
1School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, 
Scotland, United Kingdom, AB25 2ZD.  
2Institute of Dentistry, University of Aberdeen, Aberdeen, Scotland, United Kingdom, AB25 
2ZR. 
3Department of Vascular Surgery, Aberdeen Royal Infirmary, Aberdeen, Scotland, United 
Kingdom, AB25 2ZN
Word count: 3000
Corresponding author:
Dr. George Cherukara, Institute of Dentistry, University of Aberdeen, Aberdeen, Scotland, 
United Kingdom, AB25 2ZR. 
Email address: gcherukara@abdn.ac.uk
Phone number: +441224559199
Ethics statement: no application to the Research Ethics Services was required for this study.
Page 1 of 46
Confidential Material
VASCULAR
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Review Copy
2
Abstract
Objectives: Periodontal disease and tooth loss were found to be associated with several 
peripheral vascular disorders (PVD). Nonetheless, an evaluation of the literature on the 
broader domains of oral health in individuals with PVD is lacking. This systematic review 
aims to collate the current evidence on the oral health status of individuals with PVD.
Methods: Five electronic databases were searched for studies assessing oral health 
parameters in individuals with PVD. Outcome measures considered were periodontal health, 
dentition status, caries indices, oral prostheses, oral pathologies and oral hygiene behaviours. 
The Newcastle-Ottawa scale was used to appraise the quality of the studies.
Results: From 3025 records identified, 24 studies involving 1232 participants with PVD 
were included in this review. In 9 studies, periodontitis was significantly more prevalent in 
PVD compared to non-PVD participants. A further 6 studies reported individuals with PVD 
also had significantly fewer teeth and increased rates of edentulism. Only 1 study reported a 
higher incidence of dental caries in PVD participants. Other aspects of oral health such as 
oral prosthesis, oral pathology and oral hygiene behaviours were seldom assessed. 
Conclusion: The scarcity of studies reporting on broader domains limited our ability to arrive 
at a conclusion regarding the oral health status of individuals with PVD.  Future studies ought 
to assess these domains in individuals with PVD and controls to gain a more complete 
understanding of oral health and its potential association with PVD.
Keywords
Vascular medicine, peripheral vascular disease, oral health
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Introduction
Emerging evidence illustrates an association between certain oral health conditions, such as 
periodontal disease and tooth loss, and several peripheral vascular disorders (PVD).1–6 The 
International Statistical Classification of Diseases and Related Health Problems (ICD) 
defines PVD as an umbrella term for any disorder affecting blood flow in arteries or veins 
outside the heart.7 A recent meta-analysis8 reported a significantly higher risk of periodontitis 
and tooth-loss amongst individuals with peripheral arterial disease (PAD), a type of PVD, 
than healthy controls. Their review only considered periodontitis and no other essential 
aspects of oral health as per the World Health Organisation’s (WHO) manual for standardised 
oral health assessment. These include dentition status, dental erosions, oral mucosal lesions, 
dental caries, dentition and prosthesis status and oral hygiene behaviours.9 More specifically, 
dental caries and poor oral hygiene had been investigated as markers of early initiation of 
atherosclerosis, and were found to be associated with increased carotid intima-media wall 
thickness.10,11 Poor oral hygiene also increases the risk of periodontitis12 and can lead to 
increased abundance of potentially pathogenic bacteria colonising the teeth.13 These bacteria 
may exacerbate atherogenesis via the oral infection-inflammation pathway.2
Several measures have been taken by vascular surgeons regarding their patients’ dental 
health, including dental antibiotic prophylaxis to prevent vascular graft infections following 
dental sepsis.14,15 However, the oral health status of individuals with PVD remains 
incompletely assessed clinically. This is due to a lack of consensus regarding the need for 
oral health assessment in this group and whether this would warrant an improvement in 
outcomes of PVD. The aim of this study was to review the literature relating to the oral 
health status of individuals diagnosed with PVD. Further, where studies are available with 
controls (individuals without PVD), a comparison of the oral health status between these two 
groups was undertaken. 
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Methods
Search strategy
We used the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines 
(see supplemental material for the checklist) for this systematic review. The Population 
Intervention/Exposure Comparator Outcome criteria were used to form the review question – 
What are the oral health findings (O) in individuals with PVD (P) whom have undergone oral 
health assessment (I) compared to individuals without PVD (C). Electronic database and 
hand searches for articles in April 2020 were conducted in the following databases: 
MEDLINE, SCOPUS, EMBASE, Web of Science and Cochrane Central Register of 
Controlled Trials. The search strategy was formed using the Medical Subject Headings and 
relevant free-text terms and was applied to each database (Supplementary Table 1). 
Inclusion and Exclusion criteria:
Inclusion criteria:
(i) Adults aged ≥ 18 years
(ii) Individuals with any vascular disease of arteries and veins outside the heart as 
grouped under the PVD diagnosis-related groups by the ICD16 
(iii) Assessed any of the following oral health measures: dentition status, 
remaining/missing teeth, prevalence of dental disease including periodontal indices, 
dental caries indices, oral infections, oral pathology, presence/absence of oral 
prosthesis and oral hygiene behaviours
(iv) Published in English 
Exclusion criteria:
(i) Systematic or literature reviews
(ii) Case reports
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(iii) Studies with duplicate/overlapping cohorts. 
Data Extraction and quality assessment
Study characteristics and data on participants’ oral health were extracted from each included 
study and compiled on data extraction tables (Tables 1 and Supplementary 2 and 3). Titles 
and abstracts of all studies were independently screened by two reviewers (SAA and MM). 
Full texts of the selected studies were critically reviewed based on the inclusion and 
exclusion criteria. Although there were no disagreements, an arbitrator (GC) was available 
for mediation. For quality assessment, both reviewers independently used the Newcastle-
Ottawa Scale (NOS)  for case-control studies17 and a modified form for cross-sectional 
studies (Supplementary Table 4). 
Results 
Search results
The search identified 3025 studies. RefWorks (ProQuest Refworks, 2020) was used to 
process the search results and to de-duplicate 80 studies. After application of inclusion and 
exclusion criteria, 58 studies were selected for full text screening, following which 24 studies 
comprising 1232 PVD participants were included in this systematic review (Figure 1). 
Characteristics of studies 
The characteristics of studies included in this systematic review are summarised in Table 1. 
These studies were published between 1994 and 2018 and were from 14 countries. 23 studies 
were on arterial disorders and one was on a venous disorder. 13 studies compared the oral 
health status between PVD participants and healthy controls3,18–29, whilst three compared the 
oral health of PVD participants to controls with cardiac diseases.30–32 Six studies14,33–37 did 
not have controls.  Another study included controls with cardiovascular disease; however, 
they did not measure oral health in the control group.38 One study recruited edentulous PVD 
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participants as controls however no oral health assessment was conducted in this group, 
therefore a comparison was not done between cases and controls.39 
Examiner calibration and statistical power calculation
Of the 24 studies, three studies reported examiner calibration through intraclass correlation 
coefficient27, re-evaluation of random referred patients29 and another through previously 
calibrated examiners using Kappa values (0.80 to 0.97).35  Only one study provided details of  
statistical power calculation to determine sample size.29 
Case definition of PVD
The case definition of PVD vari d amongst the studies (see Table 1). Seven studies reported 
a PVD diagnosis of case groups but with no description of the parameters used to diagnose 
PVD.31–35,38,39 One study used previous medical records of vascular disease.36 Four studies 
used clinical findings of PVD as diagnostic parameters such as ankle-brachial index, clinical 
symptoms and Rose questionnaire.14,26,27,29 Stansby et al.14 reported the parameters used for 
diagnosing PAD but had only reported a diagnosis of aortic aneurysm (AA). Six studies used 
imaging parameters only such as angiography, computed tomography and Doppler 
ultrasonography.3,19–21,23,28 Six studies used a combination of clinical findings and imaging 
parameters for diagnosis of PVD.18,22,24,25,30,37
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Oral Health Measures
Periodontal health 
Periodontal health was assessed in 22 studies with results displayed in Supplementary Table 
2. The case definition of periodontitis varied across each study (see Supplementary Table 2). 
Prevalence of periodontitis and moderate to severe periodontitis was reported to be 
significantly higher in participants with arteriosclerosis obliterans25, Buerger’s disease22, 
PAD18,26,27, carotid atherosclerosis19, AA20,21 and venous thromboembolic disease (VTED)3 
compared to non-PVD participants. Two studies found no differences between groups.28,29  In 
studies with no controls, a high percentage of the PVD participants had periodontitis23,24,37 
except for one study.33 Gingivitis was more prevalent in non-PVD than in PVD participants 
in four studies.20,21,26,29 
Probing pocket depth (PPD) is a measurement of the distance from the gingival margin to the 
pocket base surrounding a tooth. This measurement is one of a range of clinical criteria used 
to diagnose and assess severity of periodontal diseases.40 Aoyama et al.30 and Çalapkorur et 
al.29  found no difference between PVD and non-PVD participants in the mean PPD. 
Çalapkorur et al.29 reported a significantly higher number of sites with PPD over 5mm 
amongst PVD participants. Likewise, a significantly higher number of sites with PPD over 
4mm were seen in AA,20,21,31,32 Buerger’s disease,22 carotid atherosclerosis19 and PAD 
participants18,27 compared to non-PVD participants. It is important to note that Çalapkorur et 
al.29 defined periodontitis as having at least 5 teeth with at least 1 site of PPD equal to or 
greater than 5mm. This differed from the other studies which defined periodontitis as the 
presence of  more than one site with PPD equal to or greater than 4mm in each quadrant. 
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Clinical attachment loss (CAL) indicates the extent of periodontal tissue support loss around 
a tooth. A significantly higher percentage of sites with CAL greater than 4mm was found 
amongst AA,20,21 Buerger’s disease22, PAD18,27 and VTED3 participants compared to non-
PVD participants. There was no significant difference in CAL greater than 4mm  between 
PVD and non-PVD participants in two studies.29,30 
Zaremba et al.38 found four of 20 participants demonstrating presence of periodontal bacteria 
in their atherosclerotic plaques after carotid endarterectomy. These participants had 
significantly higher bleeding indices and PPD greater 4mm compared to participants with no 
periodontal bacteria in the atherosclerotic plaque. Mean CAL was not significantly higher in 
the group with periodontal bacteria present in atherosclerotic plaques than those without. 
Dentition status
13 studies assessed the dentition status of PVD participants with results displayed in 
Supplementary Table 2.3,14,18,20,23,28,30–36 Nine studies compared remaining or missing teeth in 
PVD to that of non-PVD participants.3,18,20,28,30–32,34,36 All but three28,31,34 reported 
significantly less retained teeth,3,18,30,32 more missing teeth20,30,36 or higher edentulism 
rates30,36 in PVD compared to non-PVD participants. Three studies reported lower 
percentages of PVD participants who were edentulous.14,23,33 Fernandes et al.35 found that 
96.1% of teeth were missing amongst 13 PVD participants. 
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Dental Caries
Five studies investigated caries in PVD participants with findings displayed in 
Supplementary Table 3.27–29,33,35 The DMFT is the sum of the number of Decayed, Missing 
and Filled Teeth due to dental caries in the permanent teeth. It is a widely used index to 
measure dental caries and dental treatment needs amongst populations.9  Two studies 
reported the mean DMFT in PVD participants but had no controls.33,35 Calapkorur et al.29 
reported no significant difference in the DMFT of PVD compared to non-PVD participants. 
Likewise, Friedlander et al.28 found no significant difference in the mean number of carious 
retained roots or coronal/pulpal caries between PVD and non-PVD participants. Only one 
study reported a significantly higher DMFT index in PVD than non-PVD participants.27
Other oral diseases
Two studies commented on oral diseases other than caries and periodontal disease (see 
Supplementary Table 3).28,33 Friedlander et al.28 found no difference in the mean number of 
teeth with periapical lesions between PVD versus non-PVD participants. Immonen et al.33 
reported 80% of the PVD participants had an oral infection, with only 11% of them having 
“good oral health”. Candida infection was present in 17% of dentate and 47% of edentulous 
PVD participants. 54% of dentate participants had intraosseous foci compared to 20% of 
edentulous participants. Periapical lesions and intraosseous foci are areas of localised chronic 
infection of dental origin that may influence chronic systemic diseases41. 
Dental prosthesis
Three studies assessed the presence of dental prosthesis in PVD participants (see 
Supplementary Table 3).  Stansby et al.14 reported 46% PVD participants had partial 
dentures. Another study reported that amongst a total of 56 dentures in 37 PVD participants, 
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45% of dentures were poor and had to be replaced33. A third study reported the mean number 
of implants but had no controls.34
Oral hygiene behaviours
Only one study investigated oral hygiene behaviours. They used a self-reported assessment of 
oral hygiene behaviours amongst AA participants20. Compared to the non-AA group, more 
AA participants had inaccurate brushing methods, less brushing time and frequency, no 
flossing and less routine dental examinations (Supplementary Table 3). 
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Discussion
This review included broader oral health domains in the WHO’s manual to assess oral health 
in individuals. Participants with PVD were found to have compromised oral health across 
various measures such as poorer periodontal health, more missing teeth and a higher 
prevalence of edentulism in comparison to non-PVD participants. However, the findings on 
dental caries and presence of periapical lesions in PVD and non-PVD participants were 
conflicting. Although not reported in the studies, reasons for this may include differences in 
dental health-seeking behaviour in PVD participants, and in the diagnostic protocols in 
different countries.  Other aspects such as oral prosthesis, oral hygiene behaviours and oral 
pathology were seldom assessed. 
This review has also considered other subtypes of PVD such as PAD, carotid atherosclerosis, 
AA, Buerger’s disease and VTED. The assessment of oral health amongst individuals with a 
venous disorder was performed in only one of the included studies.3 Association studies 
demonstrated a possible relationship with valvular incompetence in individuals with varicose 
veins,42 the latter being a known risk factor for VTED.43 This could be mediated by the role 
of certain bacteria in periodontal disease, which were found to be risk factors for vascular 
endothelial damage and pro-coagulation.44,45  Despite Sanchez and colleagues’3 significant 
oral health findings in their cohort with a venous disorder, further studies are required to 
confirm the validity of these findings and to compare the oral health status between 
individuals with venous and arterial disorders. Two studies in Yang and colleagues’8 meta-
analysis were excluded from our review as they assessed the risk of developing PVD in 
participants with prior periodontitis.1,46
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Tooth loss in PVD participants
Several studies reported a significantly higher prevalence of tooth loss amongst PVD as 
opposed to non-PVD participants.3,18,20,30,32,36 The putative mechanisms underpinning this 
finding could be varied. Firstly, tooth loss was shown to have a possible association with 
atherosclerosis, even with adjusting for shared risk factors including age, smoking, sex, 
diabetes mellitus and hypertension.47 Secondly, an important mediator of incident tooth loss 
in PVD participants is antecedent periodontal disease. Periodontal infection via the oral 
infection-inflammation pathway, may promote systemic inflammation and exacerbate 
atherogenesis.2 Tooth loss in turn may lead to compromised masticatory ability, causing an 
altered diet which may predispose to PVD.48 Finally, the attitude and approach to dental 
disease management amongst participants and their dental care providers in different 
countries may have resulted in increased tooth loss. 
Dental prosthesis, other oral diseases and oral hygiene behaviours
The studies reporting on the presence of dental prostheses in PVD participants were non-
controlled and descriptive in nature.14,33,36 Therefore, no inference could be made on this oral 
health domain in PVD and non-PVD participants. The current literature is also insufficient to 
establish any difference between PVD and non-PVD participants regarding oral diseases such 
as Candida infections, periapical lesions and intraosseous foci. For a more complete 
assessment of these domains, further analytical studies are required. 
Poor oral hygiene behaviours have been associated with an increased risk of cardiovascular 
events and elevated concentrations of inflammatory molecules such as C reactive protein.49 
Conversely, improvements in oral hygiene have been shown to reduce the risk of 
cardiovascular events.50 Although an important determinant of oral health, oral hygiene 
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behaviour was assessed in only one study.20 That study only involved participants diagnosed 
with AA, who showed poor oral hygiene behaviours. Further analytical studies assessing oral 
hygiene behaviours in other PVD subsets are required.
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Overall appraisal of included studies and recommendations for future research 
Cross-sectional and case-control studies were the predominant study designs in this review.  
Twelve14,19,21,23–25,33–35,37–39 studies did not adjust for shared risk factors that underpin both 
tooth loss and certain types of PVD such as age, diabetes mellitus, hypertension and smoking. 
Lack of adjustments in observational studies is a known limitation.
Key methodological limitations such as the lack of control groups14,33–35,38, the use of controls 
with various cardiac30–32 or vascular24 co-morbidities, and unmatched controls have 
undermined the comparability of results between PVD and non-PVD participants. 
Furthermore, high heterogeneity of outcome measures and case definitions precluded a 
quantitative analysis. The case definitions of PVD and the clinical parameters employed for 
diagnosis were varied between the studies included. Several studies stated the diagnosis of 
PVD and its subtypes.31–35,38,39 They did not, however, describe the parameters used to make 
the diagnosis. Some studies used imaging modalities to diagnose PVD.3,20,21,23,28 These 
studies would have further benefited from categorising different PVD severities according to 
imaging findings. As this may allow correlation with associated oral health findings. This 
was evident in one study in which greater severities of periodontitis were seen with increased 
intima-media thicknesses on imaging.19  Other studies utilised a combination of clinical and 
imaging tools to diagnose PVD which would also allow correlation of PVD severity with the 
oral health findings.18,22,24,25,30,37 However, none of these studies had performed such 
correlation, which could have established whether or not  increasing PVD severities are 
associated with poorer oral health findings.   
Similarly, differences in case definitions of periodontitis, and value ranges for categorising 
different severities of periodontitis were observed. In addition, variations in the periodontal 
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indices used to assess clinical parameters of periodontal health were apparent. Such 
variations may cause inaccuracies in the prevalence of periodontitis amongst PVD 
participants.  In general, studies would benefit from using a standardised case definition of 
periodontitis as recommended by Eke et al.51 which is aimed for use in population-based 
research. Standardisation of clinical assessment parameters is also essential in future 
studies.52 
Moreover, Bloemenkamp et al.26 assessed periodontal disease using patient self-reporting. 
This method was shown to have acceptable validity for large-scale epidemiologic studies 
surveying periodontal disease.53 Nevertheless, another review indicated that employing a 
combination of self-reporting alongside other clinical indicators, such as CAL and PPD, of 
periodontal disease may be most beneficial;54 this approach was utilised in two studies.20,21  
Therefore, future studies utilising self-reporting methods amongst PVD participants may 
benefit by combining them with other parameters of assessing periodontal disease. One study 
performed periodontal examination one to two months postoperatively on PVD participants 
who had undergone vascular surgery.34 There was no mention of whether these participants 
had received dental care during that period, when their oral health may have worsened. 
The strengths of this review relate to the assessing a spectrum of essential oral health 
domains, other than periodontitis, in participants with various subtypes of PVD as per WHO 
guidance.  The principle limitation was the inability to undertake a quantitative analysis due 
to high heterogeneity of the included studies.  Additionally, only four of the 24 studies were 
considered of high quality (scores greater than six) according to the NOS scale. Further, only 
three of the 16 studies that included controls were graded as high quality. Therefore, the 
scarcity of high quality studies compromises the ability to establish a clear description of the 
oral health status amongst PVD participants. Nor does it permit a meaningful comparison to 
be made between PVD and non-PVD participants. Several recommendations for future 
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research on this topic are listed in Table 2 based on the format recommended by Brown et 
al.55 These recommendations include but are not limited to: 
- Future studies to assess the magnitude of the relationship between PVD and oral 
health parameters other than periodontal disease and tooth loss 
- Using standardised case definitions for PVD and periodontitis  
- Using standardised parameters for PVD diagnosis and oral health assessment 
according to WHO guidance and customised from Oral Health Assessment and 
Review Dental Clinical Guidance of the Scottish Dental Clinical Effectiveness 
Programme.56
- Assessing the effect of oral health treatment on PVD.
Page 16 of 46
Confidential Material
VASCULAR
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Review Copy
17
Conclusion
Due to the paucity of the high quality studies addressing oral health domains other than 
periodontal disease and tooth loss, a definitive conclusion regarding oral health 
status/conditions in individuals with PVD could not be made. Therefore, it is not yet possible 
to make an evidence-based recommendation regarding the value of routine oral health 
assessment in individuals with PVD. However, on considering the evidence regarding the 
link between oral and systemic health, it would be good practice to advise on oral health 
assessment and maintenance in individuals with PVD. 
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of literature 
search and paper selection process. 
149x149mm (144 x 144 DPI) 
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Table 1 Characteristics of included studies
N, Mean Age (± SD), M/F
Author, 
country, year
Study 
design PVD group Non-PVD group
Examiner 
calibration/
Statistical 
power 
calculation
Clinical Parameters of PVD/PVD diagnosis
Stansby et al., 
1994, England
CSS 70, 68, 32/18 N/A N/A ABI ≤ 0.90/ PAD or AA
Hamasha et al., 
1998, USA
CSS 19, 80.7, unspecified N/A N/A Medical record of atherosclerotic vascular disease
Häyrinen-
Immonen et al., 
2000, Finland
Prospective 
clinical 
study
50, 65, 33/17 N/A N/A AAA
Bloemenkamp et 
al., 2002, 
Holland
CSS 212, 48.2 ± 7.0, 0/212 475, 45.5 ± 3.1, 
0/475
N/A Clinical symptoms (Intermittent claudication, non-healing 
ulcers, gangrene); angiographic findings indicating ≥50% of 
stenosis in peripheral arteries/ PAD
Cairo et al., 2004, 
Italy
Controlled 
clinical and 
laboratory 
trial
19, 71.37 ±6.14, 14/5 21, 73.33 ± 6.11, 
15/6
N/A Carotid stenosis
Kurihara et al., 
2004, Japan
CCS 32, 73, 27/5 Unspecified N/A Angiographic, ultrasonic and CT evaluation of AAA
Iwai et al., 2005, 
Japan
CCS 14, 60, 14/0 7, unspecified, 5/2 N/A Shionoya's Criteria; angiographic findings; Allen's test/ 
Buerger’s disease
Chen et al., 2007, 
Japan
CCS 19, 56.6 ± 11, 19/0 19, 56.6 ± 11, 19/0 N/A Shionoya's Criteria; angiographic findings; Allen's test/ 
Buerger’s disease
Chen et al.,  
2008, Japan
CCS 25, 67.6 ± 10, 21/4 32, 63.10 ± 10, 28/4 N/A Clinical symptoms, angiographic findings and ABI/ PAD
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Table 1 (Continued)
Friedlander et 
al., 2010, USA
CCS 36, 64.4 ± 10.0, 
97.2%/2.8%
36, 64.9 ± 10. 10, 
97.2%/2.8%
N/A Carotid stenosis confirmed by Doppler ultrasonography
Toyofuku et al.,  
2011, Japan
CCS 53, 69.0 ± 9.1, 49/4 21, 70.6  ± 8.9, 20/1 N/A Fontaine Classification, angiographic, ultrasonic and CT 
imaging/ Arteriosclerosis obliterans
Zaremba et al., 
2012, Poland
CCS 20, 67, 13/7 unspecified N/A Internal carotid artery stenosis
Sánchez et al., 
2013, Spain
CCS 97, 60.63± 15.07, 
43/54
100, 61.86 ± 8.49, 
54/46
N/A Doppler ultrasonography and CT angiography/VTED
Soto-Barreras et 
al., 2013, Mexico
CCS 30, 63.23 ± 9.06, 
27%/73%
30, 61.86 ± 8.49, 
30%/70%
Yes/N/A ABI ≤ 0.90. <ild-to-moderate: 0.40 to 0.90 
Severe: <0.4/ PAD
Figuero et al., 
2014, Sweden
CSS 42, 68.95 ± 8.65, 
31/11
N/A N/A Carotid stenosis, PAD and AAA
Fernandes et al., 
2014, Brazil
CSS 13, 68.5 ± 10.1, 6/7 N/A Yes/N/A AA and  carotid stenosis
Suzuki et al.,  
2014, Japan
CCS 12, 70.6 ± 3.5, 9/3 25, 71.4 ± 2.1, 
60%/40%
N/A AAA
Ding et al., 
2014, 
China
CCS 89, 57.8±7.6, 79/10 59, 56.8±6.3, 44/15 N/A AA diagnosed by CT showing aortic diameter >50% than 
normal
Suzuki et al., 
2015, Japan
CCS 25, 71.4 ± 2.1, 
60%/40%
142, 68.8 ± 0.4, 
78.2%/ 21.8%
N/A AAA
Igari etl al., 
2015, Japan
CSS 58, 48, 55/3 N/A N/A Buerger’s disease diagnosed by Shionoya’s criteria
Çalapkorur et 
al., 2016, 
Turkey
CSS 40, 60.45 ± 9.94, 32/8 20, 60.4 ± 9, 18/2 N/A/Yes ABI ≤ 0.90 and Rose questionnaire/ PAD
Aoyama et al., 
2017, Japan
CSS 34, 65.6 ± 11.8, 23/11 956, 64.4 ± 13, 
693/263
N/A Clinical symptoms, ABI and angiographic findings/PAD
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Table 1 (Continued)
Nicolaiciuc et 
al., Romania, 
2018
CCS N =35
IMT > 1mm: 18
Atheroma 
plaque: 17, 
IMT > 1mm: 62.9 
(±10,2)
Atheroma plaque:
62.5(±10/8), 
IMT > 1mm: 9/9
Atheroma plaque: 
12/5
15, 40,8 (±10,9), 
4/11
N/A Evaluation done with USS to measure IMT and record 
presence of  atherosclerotic plaques/Carotid atherosclerosis
Ding et al., 
China, 
2018
CCS 169, 56.2, 30/39 156, 54.8 ± 5.0, 
129/27
N/A AA diagnosed by CT when aortic diameter >50% normal 
diameter
AA, Aortic aneurysm; AAA, Abdominal aortic aneurysm ;ABI, ankle brachial index; CCS, case-control study; CSS, cross-sectional study; CT, Computed 
tomography; F, Female IMT, intima-media thickness; M, male; PAD, peripheral artery disease; PVD, peripheral vascular disease; SD, Standard deviation; 
USS, ultrasound scan; VTED, Venous thromboembolic disease.
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Table 2 Research recommendations (based on format from Brown et al., 2006)55 
Core elements Recommendation for future research
(E) Evidence (Current) Systematic review identified predominantly cross-sectional and case-control studies
Future studies should focus on assessing the magnitude of the relationship between poor 
oral health findings and PVD 
(P) Population Adults with PVD aged ≥ 18 years old
Standardised clinical parameters for diagnosis of any subset of PVD 
(I)Intervention/exposure Standardised periodontal probing and mouth examination protocol
Assessment of oral health parameters as per the WHO’s manual for standardised oral 
health assessment using Oral Health Assessment and Review Dental Clinical Guidance 
of the Scottish Dental Clinical Effectiveness Programme56
Assessment of dental caries indices, oral pathologies, oral hygiene behaviours
(C) Comparison Adults aged ≥ 18 years old without PVD
(O) Outcomes Periodontal disease prevalence according to Eke et al.51 definition of periodontitis
Dentition status and presence of dental prosthesis in individuals with PVD
Prevalence of dental caries and oral pathologies 
Oral hygiene behaviours in individuals with PVD
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Supplementary Table 1 Population intervention/exposure comparator outcome – Search 
terms
PICO Search terms
Population Abdominal aortic aneurysm, aortic aneurysm, aneurysm, aorta, 
arterial occlusive diseases, atherosclerosis, atherosclerotic plaque, 
carotid artery diseases, carotid stenosis, intermittent claudication, 
peripheral arterial disease, peripheral vascular diseases, thrombosis, 
upper extremity deep vein thrombosis, vascular diseases, venous 
thrombosis
Intervention/Exposure Oral health, dental care
Outcome Alveolar bone loss, aggressive periodontitis, chronic periodontitis, 
dentition, dental attendance, dental caries, dental prosthesis, flossing, 
furcation defects, gingivitis, gingival diseases, mouth, mouth 
diseases, oral hygiene, oral pathology, periodontal diseases, 
periodontitis, periapical periodontitis, periapical granuloma, 
toothbrushing, tooth mobility, tooth loss
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Supplementary Table 2 Case definitions, periodontal health and dentition status findings
Author Periodontal indicesPeriodontitis case definition Dentition status Periodontal results
Stansby et al., 
1994
CPITN
Unspecified case definition
37% of PVD participants were edentate 
Dentate PVD participants had a mean 
number of 16.33 ± 9.10 teeth
0 participants with healthy tissue (CPITN 0)
4 participants with no significant pathology (CPITN 1-2)
12 participants with moderate pathology (CPITN 3)
28 participants with significant pathology (CPITN 4)
Hamasha et 
al.,1998
N/A PVD participants had significantly more 
missing teeth than controls (22.1 vs 19.5, 
p=0.01)
Edentulism was significantly higher in PVD 
participants compared to controls (57.9% vs 
32.0 %, respectively, p=0.02)
N/A
Häyrinen-
Immonen et 
al., 2000
Periodontitis diagnosis
CPI
PPD ≥3.5mm
30% of PVD participants were edentate
Mean number of teeth of PVD participants 
was 9.3
17% of AAA participants teeth has severe periodontitis.  
93% of AAA participants had poor periodontal status (CPI scores>3).
Bloemenkamp 
et al., 2002
Self-reported periodontitis
Self-reported gingivitis
Unspecified definition
N/A % of PAD participants with self-reported periodontitis was significantly 
higher than controls (31 (23%) vs 33 (8%) 3.0 (1.4–6.3) (multi-adjusted 
OR 95% CI))
% of PAD participants  with self-reported gingivitis was significantly less 
than controls (31 (23%) vs 67 (17%) 1.2 (0.6–2.2) (multi-adjusted OR 
(95%CI))
Cairo et al., 
2004
BOP, CAL, PI, PPD
(Mean ±SD)
Unspecified definition
Mean tooth loss = 13.0 ± 6.25 Mean BOP in CS participants: 58.85 ± 27.15%
Mean CAL in CS participants:  4.69 ± 1.58mm
Mean PI in CS participants: 75.95 ± 26.81%
Mean PPD in CS participants: 2.87 ± 0.82mm
Kurihara et 
al., 2004
PPD
Normal periodontal health: PPD < 
2mm
Moderate periodontitis: PPD 2-5mm
Severe periodontitis: PPD≥5mm
15% of PVD participants were edentate No AAA participants were considered to be periodontally healthy
22% of AAA participants had mild periodontitis
63% of AAA participants had severe periodontitis
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Supplementary Table 2 (Continued)
Iwai et al., 
2005
PPD
Normal periodontal health (Grade 
A) : PPD < 2mm
Moderate periodontitis (Grade B) : 
PPD 2-5mm
Severe periodontitis (Grade C): 
PPD≥5mm
Grade D: Edentulous 
N/A 0 participants in group A
4 participants in group B
9 participants in group C
1 participant in group D
Chen et al., 
2007
CAL, PPD
Mild periodontitis: less than 10% of 
site with CAL ≥4mm, 
Moderate-severe periodontitis: 
>10% sites with CAL ≥4mm
No significant difference in number of 
residual teeth between BD participants and 
controls (20.2 vs 25.7, respectively p = 
0.067
Periodontitis was significantly more prevalent in BD participants than 
controls (89.5% vs 26.7%, p <0.001). 
Moderate- severe periodontitis was significantly more prevalent in BD 
participants than controls (68.8% vs 13.1%, p<0.001).
No statistically significant difference in prevalence of mild periodontitis 
between BD participants and controls (21.1% vs 13.3%, p=1)
PD and CAL 4mm was significantly higher in BD participants (14.3% and 
22.6%, respectively) than controls (2.2% and 5.1%, respectively) p = 0.016 
and p<0.001, respectively
Chen et al, 
2008
CAL, PPD
Presence of ≥ 1 site with PPD or 
CAL ≥4mm in each quadrant
PVD participants had significantly less 
residual teeth than controls (13.2 vs 24.5, 
respectively, p<0.001)
Significantly more PAD participants were diagnosed with periodontitis 
compared to controls ( 68.0% vs 31.0% p = 0.004)
PAD participants had a significantly higher percentage of sites with CAL 
>4mm compared to controls (39.0% vs 13.4% respectively, p=0.007)
PAD participants had a significantly higher percentage of sites with PPD 
>4mm compared to controls (14.8% vs 2.6% respectively, p=0.003)
Friedlander et 
al., 2010
MPI, presence of furcal lesions, 
presence of pericoronitis
Unspecified definition
Number of missing teeth in CS participants 
was not significantly higher than controls 
(8.5 ± 6.3 vs. 7.1 ± 6.8 respectively, 
p=0.390)
No significant difference between the mean number of furcal lesions 
between CS participants and controls (1.3 ± 1.5 vs 0.8 ± 1.1 respectively, 
p=0.153)
No significant difference between the mean number of sites with 
pericoronitis between CS participants and controls (0.03 ± 1.7 vs 0.1 ± 0.7 
respectively, p=0.475)
CS participants had a significantly higher MPI than controls (15.5 ±10.4 vs 
7.9 ± 8.1 respectively, p =0.001)
Toyofuku et 
al., 2011
CAL
Periodontally healthy= PPD <4mm 
Moderate periodontitis= PPD 4-
6mm 
Severe periodontitis PPD = ≥7mm
N/A 96% of ASO participants and 100% of controls had periodontitis 
Moderate periodontitis was higher in controls than ASO participants (52% 
vs. 32% respectively)
Severe periodontitis was higher in PVD participants than controls (44% vs. 
38%)
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Supplementary Table 2 (Continued)
Zaremba et 
al., 2012
BOP, CAL. PI, PPD
Unspecified definition
N/A Mean bleeding index was significantly higher in CS participants with 
bacteria in atheromatous plaque than those without (50% vs. 24%)
% of pockets ≥4mm was significantly higher in CS participants with 
bacteria in atheromatous plaque than those without (22.8% vs 5.1%)
No significant in difference in CAL between CS participants with bacteria in 
atheromatous plaque than those without (3.88mm vs 3.51)
Sánchez et al., 
2013
BOP, CAL, CPITN, GI, PPD, 
Simplified oral hygiene index (OHI-
S)
Unspecified definition
Number of teeth in VTED participants was 
significantly less than controls ( 21.61+/-
7.77 vs. 26.80+/-2.19 respectively p<0.001)
Significantly more VTED participants were diagnosed with periodontitis 
than controls 71(73.19%) vs 45(45%) respectively, p<0.001).
BOP was significantly higher in VTED participants versus controls (45.86 ± 
35.07 vs 21.77 ± 11.33, respectively, p<0.001)
Mean CAL was statistically higher in VTED participants versus controls 
(3.84 ± 1.54 vs 1.41 ± 0.62 respectively, p<0.001)
Mean CAL was statistically higher in VTED participants versus controls 
(3.84 ± 1.54 vs 1.41 ± 0.62 respectively, p<0.001)
GI was significantly higher in VTED participants versus controls (1.56 ± 
0.95 vs 21.77 ± 1.00 ± 0.71, respectively, p<0.001)
OHI-S scores was significantly higher in VTED participants versus 
controls (1.19 ± 0.78 vs 0.17 ± 0.37, p<0.001) indicating poorer oral 
hygiene
Mean PPD was statistically higher in VTED participants versus controls 
(3.02 ± 1.27 vs 2.51 ± 0.89 respectively, p= 0.001)
Soto-Barreras 
et al, 2013
CAL
CAL ≥ 4mm in 30% of measured 
sites
N/A More PAD participants were diagnosed with periodontitis compared to 
controls (90% vs 56%)
Presence of PD and AL 4mm was significantly higher in PAD group than 
controls (16.3% and 45.1%, respectively) vs. (9.3% and 27.4%, respectively) 
p = 0.0272
PAD showed a positive association with  periodontitis ( OR = 8.18; 95% CI 
= 1.21 to 35.23; p = 0.031)
Fernandes et 
al, 2014
Healthy Sextants, Bleeding 
Sextants, Presence of Calculus, PPD
Unspecified definition
Out of 13 PVD participants, 400 (96.1%) 
teeth were missing
No healthy sextants were detected in PVD participants
No bleeding sextants were detected in PVD participants
1.3% of sextants had calculus
1.3% of sextants had PPD 4-5mm. 
No sextants had PPD> 6mm
Figuero et al, 
2014
BOP, Furcation, Mobility, Plaque 
scores, PPD
No significant difference between the 
number of residual teeth of PVD participants 
Mean BOP was 63.11% ± 22.85%.
Mean number of teeth with furcation involvement was 2.68 ± 2.20
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Supplementary Table 2 (Continued)
Unspecified definition vs controls (20.2 vs 25.7 respectively, 
p=0.067)
Mean number of mobile teeth was 0.68 ± 1.47
45% of PVD participants had a periodontitis diagnosis
Mean plaque scores in PVD participants were 68.74% ± 22.85%
Mean number of pockets of 4mm was 13.92 ± 7.82
Mean number of pockets of 5-6mm was 8.39 ± 8.42. 
Mean number of pockets >7mm was 1.89 ± 3.79
Mean number of suppurating pockets was 3.58 ± 8.45
Suzuki et al, 
2014
BOP, CPI, PPD
Unspecified definition
Number remaining teeth statistically 
comparable between AAA participants and 
controls (16.8 ± 2.8 vs 19.8 ± 1.6 
respectively)
BOP was Statistically comparable between AAA participants and controls
CPI was Statistically comparable between AAA participants and controls
AAA participants had significantly higher PPD than controls (3.01 ± 
0.26mm vs2.52 ± 0.05 mm respectively, p<0.05)
Ding et al, 
2014
BOP, BI, CAL, PD, PLI
Mild: CAL 1-2mm
Moderate periodontitis: CAL 3-
4mm
Severe peridontitis:  CAL >5mm
N/A Gingivitis was significantly higher in controls than in AA participants (18 vs 
5, respectively p<0.01)
Mild periodontitis was significantly higher in controls than AA participants 
(25 vs 15,l respectively p<0.01)
Moderate (36 vs 4,  p<0.01)  and severe periodontitis (33 vs 5, p<0.01) was 
significantly higher in AA participants than controls
BI , CAL, PD, PLI were all significantly higher in AA participants than 
controls
BI (3.4 ± 0.5 vs 2.1 ± 0.7 respectively, p<0.01)
CAL (4.7 ±0 .8 vs 3.0 ± 0.7 respectively, p<0.01)
PLI (|2.4 ± 0.6 vs 2.0 ± 0.6 respectively, p<0.01)
PD (5.2 ± 0.8 vs 4.3 ± 0.7 respectively, p<0.01
Igari et al, 
2015
PD
Normal (Grade A) : PD < 2mm
Moderate periodontitis (Grade B) : 
PD 2-5mm
Severe periodontitis (Grade C): PD 
> 5mm
Grade D: Edentulous
N/A Consent was only sought from 19 of the 58 BD participants
Grade A: 1 BD participant
Grade B: 7 BD participants
Grade C: 9 BD participants
Grade D: 2 BD participants
More than half of the BD participants (11 out of 19)  had severe periodontitis
Suzuki et al, 
2015
BOP, CPI, PPD
Unspecified definition
PVD participants had significantly less 
residual teeth than controls (14.6 ± 2.0 vs 
20.9 ± 0.7 respectively, p<0.05)
BOP was statistically comparable between AAA participants and controls
CPI was statistically comparable between AAA participants and controls
AAA participants have significantly higher PPD than controls (3.01 ± 
0.26mm vs 2.52 ± 0.05 mm respectively, p<0.05)
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Supplementary Table 2 (Continued)
Çalapkorur et 
al,  2016
BOP, CAL, GI, Gingivitis diagnosis, 
PI, PPD
Chronic periodontitis defined as the 
presence of at least 5 teeth with ≥1 
site of PPD ≥5mm, CAL ≥2mm, 
BOP and 30% radiographic bone 
loss. 
N/A No significant difference between BOP of  PAD participants and controls 
(5.18 vs 3.41 respectively, p = 0.058)
No significant difference  between mean CAL of  PAD participants  and 
controls (3.88 ± 0.91 vs 3.82 ± 0.69 respectively, p = 0.642)
No significant difference between median plaque indices of  PAD 
participants  and controls (2.00 vs 1.91 respectively, p = 0.456)
No significant difference between median PPD of  PAD participants and 
controls (2.5 vs 2.1 respectively, p = 0.072)
No significant difference between PAD participants and controls in localised 
(21% vs 5% respectively) and generalised (9% vs 3% respectively) chronic 
periodontitis
Aoyama et al, 
2017
BOP, CAL, PPD
Unspecified definition
Edentulism was significantly higher in PVD 
participants compared to controls (18% vs 
5%, respectively, p=0.0139)
PVD participants had significantly more 
missing teeth than controls (17.5 ± 11 vs 
10.9 ± 8.7, respectively, p <0.0001)
Mean PPD was not significantly different between PAD participants and 
controls (2.28 ± 0.4mm vs 2.42 ± 0.58mm respectively, p= 0.2021)
Mean CAL was not significantly different between PAD participants and 
controls (2.90 ± 0.88mm vs 3.10 ± 1.07mm respectively, p= 0.5979)
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Supplementary Table 2 (Continued)
Nicolaciuc et 
al, 2018
BOP, CAL, PD, PI
Mild periodontitis: CAL between 1-
2 mm
Moderate periodontitis: CAL 
between 3-4 mm
Severe periodontitis: CAL > 5mm
N/A  Mean BOP was not significantly different between PVD 
participants and controls (16.00 ± 18.80% vs 16.20 ± 20.20% 
respectively, p= 0.9569)
 Mean BOP was significantly higher in IMT > 1mm and atheroma 
group vs controls (43.4 ± 32.1 and 31.6 ± 23.4, respectively vs 35.7 
± 24.6)
 Participants with PD > 4mm was significantly higher in IMT > 
1mm and atheroma group than controls (6 and 12, respectively vs 4, 
p=0.022)
 Mean number of sites with PD > 4mm was significantly higher in 
IMT > 1mm and atheroma group vs controls ( 33.8 ± 32.3 and  51.1 
± 31.1, respectively vs 35.4 ± 51.3, p = 0.040)
 Participants with superficial periodontitis was significantly higher 
in controls than IMT > 1mm and atheroma group (8 vs 4 and 2, 
respectively)
 Participants with moderate periodontitis was significantly higher in 
IMT > 1mm group and atheroma group than controls (8 and 3, 
respectively vs 5)
 Mean number of sites with PD > 4mm was significantly higher in 
IMT > 1mm and atheroma group vs controls ( 33.8 ± 32.3 and 51.1 
± 31.1, respectively vs 35.4 ± 51.3, p = 0.040
 Participants with superficial periodontitis was significantly higher 
in controls than IMT > 1mm and atheroma group (8 vs 4 and 2, 
respectively)
 Participants with moderate periodontitis was significantly higher in 
IMT > 1mm group and atheroma group than controls (8 and 3, 
respectively vs 5)
 Participants with moderate periodontitis was significantly higher in 
IMT > 1mm group and atheroma group than controls (8 and 3, 
respectively vs 5)
 Participants with severe periodontitis was significantly higher in 
IMT > 1mm and atheroma groups than controls ( 6 and 12, 
respectively vs 2, p = 0.006)
Ding et al, 
2018
BOP, CAL, PD, PI
Classification of Periodontal 
Missing teeth was significantly higher in 
AA participants than controls (1.7 vs 0.5 
Gingivitis prevalence was significantly higher in controls compared to AA 
participants (54 (34.6% vs 21 (12.4%) respectively, p = 0.000)
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Supplementary Table 2 (Continued)
Diseases and Conditions used to 
diagnose chronic periodontitis
respectively, p = 0.000) Periodontitis prevalence was significantly higher AA participants than 
controls ( 148 (87.6%) vs 87 (55.8%) respectively, p = 0.000)
Mild periodontitis was significantly higher in controls compared to AA 
participants ( 31 (18.3%) vs 62 (39.7|%) respectively, p = 0.000)
Moderate periodontitis was significantly higher in  AA participants 
compared to controls (89 (52.7%) vs 15 (9.6%) respectively, p = 0.000)
Severe periodontitis was significantly higher in AA participants than 
controls (28 (16.6%) vs 10 (6.4%), p = 0.000)
BI was significantly higher in AA participants than controls (3.0 ± 0.5 vs 2.1 
± 0.7 respectively, p = 0.000)
CAL was significantly higher in AA participants than controls (3.09 ± 1.27 
vs 2.25 ± 1.03 respectively, p = 0.000)
PD was significantly higher in AA participants than controls (3.55 ± 0.52 vs 
2.29 ± 0.49 respectively, p = 0.000)
PI was significantly higher in AA participants than controls (2.4 ± 0.6 vs 2.0 
± 0.4 respectively, p = 0.000
AA: Aortic aneurysm; BD: Buerger’s disease; BOP: bleeding on probing; CAL; clinical attachment loss; CI: Confidence interval; CPI: Community 
Periodontal Index; CPITN: Community Periodontal Index of Treatment Needs; CS: Carotid stenosis DMFT: decayed, missing, filled teeth; GI: 
Gingival index; IMT: Intima-media thickness; MPI: Mattila Pantomography Index; OHI-S: simplified oral hygiene index; OR: Odds ratio;  PI: plaque 
index; PPD; pocket probing depth;  PVD: peripheral vascular disease; SD: Standard deviation; VTED: Venous thromboembolic disease
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Supplementary Table 3 Dental caries, oral pathology, oral infection, oral hygiene behaviours, oral prosthesis indices and findings
Author Dental caries (Indices used 
and findings)
Oral pathology (Indices used and 
findings)
Oral hygiene behaviours (Indices used and 
findings)
Oral prosthesis
(Indices used and findings)
Stansby et al, 1994 N/A N/A N/A  Presence of dentures
32 (46%) of PVD participants 
had partial dentures
Häyrinen-
Immonen et al, 
2000
 DMFT 
 Number of teeth with 
deep caries
Overall mean DMFT of AAA 
participants: 26 ± 4.8
1 participant had deep caries, 
and this tooth had to be 
extracted for this reason
19 (54%) of dentate AAA 
participants had interosseous 
foci
3 (20%) of edentate AAA 
participants had interosseous 
foci
 Interosseous foci
 Presence of Candida infection
41 (80%) AAA participants had oral 
infection. 
13 AAA participants (26%) suffered from 
oral Candida infection.
N/A  Number of dentures
37 participants had a total of 56 
dentures with 45% of them being 
too old, unfit or broken
Friedlander et al, 
2010
 Caries index
Mean number of teeth with 
coronal/pulpal caries was 
statistically comparable 
between CS participants and 
controls (2.4 ± 3.5 vs 2.1 ± 2.5, 
respectively, p=0.689
 Number of retained roots with 
carious lesions 
 Number of teeth with periapical 
lesions
Mean number of carious retained roots was 
not significantly different between CS 
participants and controls (1.4 ± 1.6 vs 0.8 ± 
1.6, respectively, p=100). Mean number of 
teeth with periapical lesions between CS 
participants and controls was not 
statistically significant (1.5± 2.4 vs 0.8 ± 
1.5 respectively, p=0.109)
N/A N/A
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Supplementary Table 3 (Continued)
Soto-Barreras et al, 
2013
 DMFT
Participants with PAD had a 
significantly higher DMFT 
index than controls (21.4 +/- 2.6 
vs 18.3 +/- 3.4, p<0.0002)
N/A N/A N/A
Fernandes et al, 2014  DMFT
Mean DMFT of PVD 
participants was 31.5 ± 1.4
N/A N/A N/A
Figuero et al, 2014 N/A N/A N/A  Number of implants
Mean number of implants: 0.45 
+/-1.47 
Çalapkorur et al, 
2016
 DMFT
Mean DMFT of PAD 
participants was statistically 
comparable to controls (14.60 ± 
5.46 vs 12.65 ±6.30, p= 0.221)
N/A N/A N/A
Ding et al, 2018 N/A N/A  Brushing method: Horizontal brushing 
was significantly higher in AA 
participants than controls (63 vs 16 
respectively, p = 0.000). Vertical 
brushing was significantly higher in 
Controls than AA participants (96 vs 44 
respectively, p = 0.000). Mixed 
brushing was not significantly different 
between AA participants and controls 
(62 vs 44 respectively, p = 0.000)
 Frequency, time and sites: Brushing < 1 
time/day was significantly higher in AA 
participants than controls (82 vs 47 
respectively) whereas brushing ≥ 1 
time/day was significantly higher in 
controls than participants (87 vs 109 
respectively p = 0.001). Brushing time
N/A
Page 40 of 46
Confidential Material
VASCULAR
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Review Copy
Supplementary Table 3 (Continued)
<1minute was significantly higher in 
AA participants than controls (95 vs 52 
respectively) whereas >3minute was 
significantly higher in controls than AA 
participants (34 vs 16 respectively, p = 
0.002). Brushing every surface was 
significantly more in controls than AA 
participants (92 vs 76 respectively, p = 
0.012)
 Average lifespan of toothbrush: 
Lifespan of a tooth brush more than 
three months was seen significantly 
more in AA participants than controls 
(139 vs 102 respectively, p = 0.001)
 Flossing: Absence of flossing was 
significantly higher in AA participants 
than controls (163 vs 141 respectively, 
p = 0.012)
 Supragingival scaling: Supragingival 
scaling <once/year was significantly 
higher in AA participants than controls 
(160 vs 128 respectively, p = 0.000)
 Dental appointments: Absence of 
periodic dental examination was 
significantly higher in AA participants 
than controls (154 vs 124 respectively, 
0.003)
AA: Aortic aneurysm; CS: Carotid stenosis; DMFT: Decayed, missing, filled teeth; PAD: Peripheral arterial disease; PVD: Peripheral vascular disease.
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Supplementary Table 4 Quality assessment of the included studies using the Newcastle 
Ottawa Scale (N = 24)
Author, year Selectiona Comparabilityb Outcomec Score
Stansby et al.,199414 *** 0 * 4
Hamasha et al., 199836 *** ** ** 7
Hayrinen-Immonen et al., 200033 * 0 * 2
Bloemenkamp et al., 200226 ** ** * 5
Cairo et al., 200439 ** 0 0 2
Kurihara et al., 200423 * 0 0 1
Iwai et al., 200524 ** 0 0 2
Chen et al., 200722 ** ** ** 6
Chen et al., 200818 *** ** ** 7
Friedlander et al. 201028 ** ** ** 6
Toyofuku et al., 201125 *** 0 * 4
Zaremba et al., 201238 * 0 * 2
Sánchez et al., 20133 *** * ** 5
Soto-Barreras et al., 201327 *** ** * 6
Figuero et al., 201434 *** 0 0 3
Fernandes et al., 201435 * 0 * 2
Suzuki et al., 201431 * * ** 4
Ding et al., 2014 *** * ** 6
Suzuki et al., 201532 * 0 * 2
Igari et al., 2015 *** 0 * 4
Çalapkorur et al., 201429 *** ** ** 7
Aoyama et al., 201730 ** ** ** 6
Nicolaiciuc et al., 201819 *** 0 ** 5
Ding et al., 201820 **** ** ** 8
a A maximum of five stars can be awarded for selection
b A maximum of two stars can be awarded for comparability
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c A maximum of three stars can be awarded for outcome
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PRISMA 2009 Checklist
Section/topic # Checklist item Reported on page # 
TITLE 
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1
ABSTRACT 
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number. 
2
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known. 3
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS). 
4
METHODS 
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
Not 
applicable
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale. 
4
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched. 
4
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated. 
4
Supplemental 
table 1
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis). 
5
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators. 
5
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
5
Supplemental 
table 1
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis. 
5
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PRISMA 2009 Checklist
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). Not 
applicable
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis. 
5
Page 1 of 2 
Section/topic # Checklist item Reported on page # 
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies). 
5
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified. 
Not 
applicable
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram. 
5
Figure 1
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
5,6
Table 1
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). 5
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
7,8,9,10
Table 2 
and 3
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. Not 
applicable
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). 5
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). Not 
applicable
DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers). 
11, 12, 13
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias). 
14,15,16
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PRISMA 2009 Checklist
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 17
Table 4
FUNDING 
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review. 
17
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. 
doi:10.1371/journal.pmed1000097 
For more information, visit: www.prisma-statement.org. 
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